HemaSphere (Aug 2023)

P898: A PROSPECTIVE PHASE 2 STUDY TO ASSESS MINIMAL RESIDUAL DISEASE AFTER IXAZOMIB, LENALIDOMIDE, DEXAMETHASONE (IRD) TREATMENT FOR NEWLY DIAGNOSED TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS

  • Raija Silvennoinen,
  • Anu Partanen,
  • Anders Waage,
  • Valdas Pečeliūnas,
  • Fredrik Schjesvold,
  • Pekka Anttila,
  • Katarina Uttervall,
  • Marjaana Säily,
  • Mervi Putkonen,
  • Kristina Carlson,
  • Einar Haukas,
  • Marja Sankelo,
  • Damian Szatkowski,
  • Markus Hansson,
  • Anu Marttila,
  • Per Axelsson,
  • Ronald Svensson,
  • Birgitta Lauri,
  • Maija Mikkola,
  • Conny Karlsson,
  • Johanna Abelsson,
  • Erik Ahlstrand,
  • Anu Sikiö,
  • Monika Klimkowska,
  • Reda Matuzeviciene,
  • Mona Hoyseter Fenstad,
  • Sorella Ilveskero,
  • Hareth Nahi

DOI
https://doi.org/10.1097/01.HS9.0000970496.55340.69
Journal volume & issue
Vol. 7
p. e5534069

Abstract

Read online

No abstracts available.